Highlighted by the antibiotic nonproprietary USAN/INN name approvals listed below:
BrandinstituteDecember 8, 2020
All | Rx Brand | Nonproprietary (USAN/INN) | Covid-19 | Consumer | Brand Showcase | Medical Device | Sponsorship | DSI Guidance | BI Culture
Highlighted by the pain & inflammation nonproprietary USAN/INN name approvals listed below:
BrandinstituteDecember 8, 2020
Highlighted by the metabolic disorder nonproprietary USAN/INN name approvals listed below
BrandinstituteNovember 20, 2020
Highlighted by the ophthalmology nonproprietary USAN/INN name approvals listed below
BrandinstituteNovember 20, 2020
Highlighted by the dermatology nonproprietary USAN/INN name approvals listed below:
BrandinstituteNovember 16, 2020
Highlighted by the cardiovascular nonproprietary USAN/INN name approvals listed below:
BrandinstituteOctober 27, 2020
Highlighted by the immunology nonproprietary USAN/INN name approvals listed below:
BrandinstituteOctober 26, 2020
Highlighted by the hematology nonproprietary USAN/INN name approvals listed below:
BrandinstituteOctober 19, 2020
Important Update: The 72nd INN Consultation of the World Health Organization....
BrandinstituteApril 2, 2020
Ms. Fuerst is President of Drug Safety Institute's Nonproprietary (USAN/INN) Names Division.
BrandinstituteOctober 21, 2019